Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 19, Issue SUPPL. 2, 2008, Pages

  Oberg, K ^a,c   Jelic, S ^b,c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^c ESMO HEAD OFFICE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; FLUORODEOXYGLUCOSE F 18; PENTETREOTIDE; SOMATOSTATIN DERIVATIVE;

AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LASER SURGERY; LIVER METASTASIS; MEDICAL SOCIETY; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PANCREAS TUMOR; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; STOMACH TUMOR; TREATMENT PLANNING; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR SCINTISCANNING; VON HIPPEL LINDAU DISEASE; GASTROINTESTINAL TUMOR; INCIDENCE; PATHOLOGY;

FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HUMANS; INCIDENCE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS;

EID: 45149104363     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn117     Document Type: Article

References (10)

1. Modlin IM, Lye KD, Kidd M, A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934-959.
2. Berge T, Unell F. Carcinoid tumours. Frequency in a defined population during a 12-year period. Acta Pathol Microbiol Scand A, 1976; 84: 322-330.
3. Chandrasekharappa SC et al. Postonal cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997; 276: 404-407.
4. Latif F et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260: 1317-1320.
5. Solcia E, Kloppel G, Sobin L. Histological typing of endocrine tumours, in World Health Organizabon Histological Classification of Tumours, 2nd edn. Berlin: Springer 2000; 38-74.
6. Eriksson B, Oberg K, Stridsberg M. Tumor markers in neuroendocrine tumors. Digestion 2000; 62 (Suppl 1): 33-38.
7. Ricke J et al. Standardisation of imaging in neuroendocrine tumours: results of a European delphi process. Eur J Radiol 2001; 37: 8-17.
8. Hellman P et al. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World J Surg 2002; 26: 991-997.
9. Oberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol 2001; 12 (Suppl. 2): S111-S114.
10. Kwekkeboom DJ et al. [177Lu-DOTAOTyr3]octreotate: Comparison with [111In-DTPAo]octreotide in patients. Eur J Nucl Med 2001; 28: 1319-1325.